Chris A. Rallis - 03 Mar 2023 Form 4 Insider Report for FENNEC PHARMACEUTICALS INC. (FENC)

Role
Director
Signature
/s/ Chris A. Rallis
Issuer symbol
FENC
Transactions as of
03 Mar 2023
Net transactions value
-$9,791
Form type
4
Filing time
03 Mar 2023, 16:35:20 UTC
Previous filing
17 Nov 2022
Next filing
17 Apr 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FENC Common Shares Options Exercise $9,998 +4,166 +14% $2.40 34,184 03 Mar 2023 Direct F1
transaction FENC Common Shares Tax liability $19,789 -2,177 -6.4% $9.09 32,077 03 Mar 2023 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents options granted April 3, 2013, with a $2.40 USD strike price and expiration of April 3, 2023.
F2 Represents shares automatically sold pursuant to a 10b5-1 plan to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the exercise of 4,166 shares from an April 3, 2013 grant.